110 related articles for article (PubMed ID: 21275596)
1. Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series.
Mangat SS; Ramasamy B; Prasad S; Walters G; Mohammed M; Mckibbin M
Semin Ophthalmol; 2011 Jan; 26(1):1-3. PubMed ID: 21275596
[TBL] [Abstract][Full Text] [Related]
2. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy.
Menezo V; Cuthbertson F; Downes SM
Retina; 2010 Oct; 30(9):1400-4. PubMed ID: 20224465
[TBL] [Abstract][Full Text] [Related]
3. Management of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) - a holistic approach.
Cornish KS; Lim LT; Imrie F
Semin Ophthalmol; 2012; 27(1-2):29-32. PubMed ID: 22352824
[TBL] [Abstract][Full Text] [Related]
4. Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.
Jyothi S; Chowdhury HR; Chong V; Sivaprasad S
Eye (Lond); 2010 Jun; 24(6):1018-23. PubMed ID: 19893588
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
6. Myopic choroidal neovascularization.
Ruiz-Moreno JM; López-Gálvez MI; Donate J; Gomez-Ulla F; García-Arumí J; García-Layana A; Sellés I; Reche J; Montero JA; Pazos B; Zapata MA; Pastor JC
Ophthalmology; 2011 Dec; 118(12):2521-3. PubMed ID: 22136676
[No Abstract] [Full Text] [Related]
7. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
Pai SA; Shetty R
Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
[No Abstract] [Full Text] [Related]
8. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
[TBL] [Abstract][Full Text] [Related]
9. Limited long-term efficacy of intravitreous anti-VEGF pharmacotherapy in sarcoidosis complicated by peripapillary choroidal neovascular membrane.
Shah SP; Hubschman JP; Bourges JL; Hu AY; Schwartz SD
Acta Ophthalmol; 2010 Sep; 88(6):e243-4. PubMed ID: 19740129
[No Abstract] [Full Text] [Related]
10. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
[TBL] [Abstract][Full Text] [Related]
11. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.
Heier JS; Brown D; Ciulla T; Abraham P; Bankert JM; Chong S; Daniel PE; Kim IK
Ophthalmology; 2011 Jan; 118(1):111-8. PubMed ID: 20678799
[TBL] [Abstract][Full Text] [Related]
12. Photoreceptor reconstitution correlates with visual improvement after intravitreal bevacizumab treatment of choroidal neovascularization secondary to traumatic choroidal rupture.
Francis JH; Freund KB
Retina; 2011 Feb; 31(2):422-4. PubMed ID: 21240036
[No Abstract] [Full Text] [Related]
13. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
Mavrakanas N; Mendrinos E; Tabatabay C; Pournaras CJ
Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
[No Abstract] [Full Text] [Related]
14. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
Carneiro AM; Silva RM; Veludo MJ; Barbosa A; Ruiz-Moreno JM; Falcão MS; Brandão EM; Falcão-Reis FM
Ophthalmologica; 2011; 225(2):81-8. PubMed ID: 20881442
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
[TBL] [Abstract][Full Text] [Related]
16. Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use.
Chaikitmongkol V; Bressler NM
JAMA Ophthalmol; 2013 Feb; 131(2):260-2. PubMed ID: 23411901
[No Abstract] [Full Text] [Related]
17. Multifocal outer retinopathy in a patient with multifocal inner choroidopathy.
Chen FK; Tufail A
Clin Exp Ophthalmol; 2011; 39(7):700-3. PubMed ID: 22452687
[No Abstract] [Full Text] [Related]
18. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.
Barth T; Zeman F; Helbig H; Gamulescu MA
Int Ophthalmol; 2018 Jun; 38(3):923-931. PubMed ID: 28424992
[TBL] [Abstract][Full Text] [Related]
19. Ranibizumab in the treatment of choroidal neovascularization associated with morning glory syndrome.
Cennamo G; Rossi C; Velotti N; de Crecchio G
Acta Ophthalmol; 2015 Sep; 93(6):e516-7. PubMed ID: 25726749
[No Abstract] [Full Text] [Related]
20. Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane.
Shah N; Shah U
Indian J Ophthalmol; 2008; 56(2):163-4. PubMed ID: 18292635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
